文献速递临床生化临床血液与体液质量管理与危急值

中国临床实验室Delta检查全国性调查

National survey on delta checks in clinical laboratories in China.
PubMed 文献 · Clin Chem Lab Med · 2020-01-01

本研究通过全国性在线调查了解中国临床实验室Delta检查现状,调查分两部分:一般情况调查和2019年6月1日至30日Delta检查警报记录。结果显示最常用分析物为钾、葡萄糖、肌酐(生化)和血红蛋白、血小板、白细胞(血液),中位最大标本间隔5天,最常见计算模式为百分比变化和绝对变化。

要点

  • 生化Delta检查最常用钾、葡萄糖、肌酐,血液最常用血红蛋白、血小板、白细胞。
  • 所有分析物中位最大标本间隔为5天,常用计算模式为百分比变化和绝对变化。
  • 警报最常见原因为患者接受治疗,其次为生理状态改变和溶血、脂血、黄疸干扰。

核心结论

  • 这是中国首次全国性Delta检查调查,有助于了解中国临床实验室Delta检查现状。

研究设计与样本

  • 全国性在线调查,分两部分:一般情况调查和2019年6月1日至30日Delta检查警报记录。

主要发现

  • 生化Delta检查最常用分析物为钾、葡萄糖、肌酐,血液为血红蛋白、血小板计数、白细胞计数。
  • 所有分析物中位最大标本间隔为5天。
  • 中国临床实验室最常用Delta检查计算模式为百分比变化和绝对变化。
  • 生化和血液Delta检查警报涉及最多的分析物分别为钾和血红蛋白。
  • Delta检查警报最常见原因为患者接受治疗,其次为患者生理状态改变和溶血、脂血、黄疸干扰。

关键数值与推荐

  • 生化Delta检查最常用分析物:钾、葡萄糖、肌酐。
  • 血液Delta检查最常用分析物:血红蛋白、血小板计数、白细胞计数。
  • 所有分析物中位最大标本间隔:5天。
  • 常用Delta检查计算模式:百分比变化和绝对变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background This study aimed to understand the status quo of delta checks in Chinese clinical laboratories through a nationwide online survey. Methods The survey was divided into two parts. The first part was a general situation survey in which clinical laboratories had to provide information about the laboratories, including delta checks used. In the second part, clinical laboratories were asked to record the delta check alerts generated in their laboratories from June 1st, 2019 to June 30th, 2019. Results The most frequently used analytes in delta checks were potassium (K), glucose (Glu), creatinine (Cre) for clinical chemistry and hemoglobin (Hgb), platelet (PLT) count and white blood cell (WBC) count for clinical hematology. The median maximum time interval between specimens for all analytes was 5 days. The most commonly used delta check calculation modes in Chinese clinical laboratories were percentage change and absolute change. K and Hgb were the analytes most involved in clinical chemistry and clinical hematology delta check alerts. The most common causes of delta check alerts were that the patients had received treatment, which was followed by the change in the patient's physiological state and interference from hemolysis, lipemia and icterus. The two most common outcomes of delta check alerts were 'no problems found, standard report issued' and 'no problems found, report issued with comment'. Conclusions This study was the first nationwide survey of delta checks in China, the results of which help us to understand the current situation of delta checks in Chinese clinical laboratories.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. He S, Kang F, Wang W, et al. National survey on delta checks in clinical laboratories in China. Clin Chem Lab Med. 2020. PMID: 31927514. doi:10.1515/cclm-2019-1131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。